Lista de obras -

A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival

scientific article published on 05 December 2018

Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens

scientific article published on 01 January 2002

Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice

artículo científico publicado en 2002

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

artículo científico publicado en 2005

Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene

artículo científico publicado en 2011

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.

artículo científico publicado en 2014

Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulin

artículo científico publicado en 2013

Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.

artículo científico publicado en 2004

Exuberated numbers of tumor-specific T cells result in tumor escape.

artículo científico publicado en 2008

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

artículo científico publicado en 2005

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

artículo científico publicado en 2004

Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin

scientific article published on 01 January 2006

Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.

artículo científico publicado en 2005

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models

artículo científico publicado en 2018

Optimizing T-cell receptor avidity with somatic hypermutation

artículo científico publicado en 2019

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

artículo científico publicado en 2006

Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptides

artículo científico publicado en 2013

The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota

artículo científico publicado en 2017

The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.

artículo científico publicado en 2009

Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.

artículo científico publicado en 2005

mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model

artículo científico publicado en 2016

mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity

artículo científico publicado en 2015

“First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation.

artículo científico publicado en 2013

Lista de obras de

A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival

Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens

Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.

Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulin

Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.

Exuberated numbers of tumor-specific T cells result in tumor escape.

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin

Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models

Optimizing T-cell receptor avidity with somatic hypermutation

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptides

The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota

The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.

Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.

mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model

mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity

“First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation.